Back to today’s briefing

Story perspectives

Pfizer's Stock Hits Decade Low, But Promises Growth

1/24/2025

25 4

Summary

Story summary

Pfizer Inc. (PFE) is facing a decade-low stock price, sparking investor curiosity. While COVID-related sales have dipped, the company boasts a robust 6.3% dividend yield and a 14% rise in non-COVID revenue. With analysts forecasting an 8% annual growth fueled by oncology projects, Pfizer’s low P/E ratio of 9 hints at a promising investment opportunity.

1 of 1

Story summary

Pfizer Inc. (PFE) is facing a decade-low stock price, sparking investor curiosity. While COVID-related sales have dipped, the company boasts a robust 6.3% dividend yield and a 14% rise in non-COVID revenue. With analysts forecasting an 8% annual growth fueled by oncology projects, Pfizer’s low P/E ratio of 9 hints at a promising investment opportunity.